Reported about 21 hours ago
Analysts project that the EU's trade deal with the US could impose a 15% tariff on branded medicines, potentially costing the pharmaceutical industry between $13 billion and $19 billion. This increase in expenses might result in higher consumer prices unless companies implement mitigation strategies. The deal includes some exemptions for generic drugs, but uncertainties remain until the agreement is finalized.
Source: YAHOO